爭光股份(301092.SZ):子公司寧波爭光今起有序復工復產
格隆匯12月20日丨爭光股份(301092.SZ)公佈,公司全資子公司寧波爭光樹脂有限公司(簡稱“寧波爭光”)於2021年12月9日披露了《關於全資子公司寧波爭光樹脂有限公司受疫情影響臨時停產的提示性公吿》。為全力配合政府防疫工作,寧波爭光已按照疫情防控相關要求於2021年12月10日起臨時停產。
根據寧波市新冠肺炎疫情防控工作領導小組2021年12月19日發佈的通吿,寧波爭光於2021年12月20日開始有序復工復產,力爭將該次疫情的影響降到最低。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.